Please ensure Javascript is enabled for purposes of website accessibility

Why HealthEquity Stock Was Winning Big This Week

By Eric Volkman – Jan 13, 2022 at 10:22PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company unveiled some highly encouraging growth statistics.

What happened

Shares of health savings account (HSA) specialist HealthEquity (HQY 1.36%) were zooming well into the black this week. As of Thursday's market close, its stock was up by almost 10% week-to-date thanks to some encouraging statistics the company released on Tuesday.

So what

HealthEquity issued a business update that morning in advance of a company presentation at a healthcare industry conference. The figures released show that it's poised for well better-than-expected results for both 2021 as a whole, and for at least the early part of this year.

Jar stuffed with U.S. coins and currency, labeled "H.S.A." next to a piggy bank.

Image source: Getty Images.

It wrote in the update that the total number of HSAs in its portfolio is expected to be roughly 7.2 million as of this coming Jan. 31. That's a sturdy improvement of around 24% year over year.

As that figure goes, so goes total HSA assets. HealthEquity's estimate for that line item is approximately $19.8 billion, representing growth of roughly 38%.

All told, the company is forecasting that its end-year number of total accounts will be around the 14.4 million mark, which is about 13% higher than the tally at the end of 2020.

HealthEquity credited "record new openings and custodial asset growth" for the boost in its metrics.

Now what

The update was a particularly welcome development for HealthEquity investors, many of whom were surely still displeased after their company released disappointing third-quarter results in early December. In unveiling those quarterly figures, HealthEquity cut its guidance for both revenue and per-share net profit.

While the company didn't provide new forecasts for either of the two line items in its business update, those nicely rising metrics bode well for its financials. No wonder investors have suddenly gotten more bullish on the stock.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns and recommends HealthEquity. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.